376 related articles for article (PubMed ID: 26575701)
1. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
Huerta A; López B; Ravassa S; San José G; Querejeta R; Beloqui Ó; Zubillaga E; Rábago G; Brugnolaro C; Díez J; González A
J Hypertens; 2016 Jan; 34(1):130-8. PubMed ID: 26575701
[TBL] [Abstract][Full Text] [Related]
2. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction.
González A; López B; Querejeta R; Zubillaga E; Echeverría T; Díez J
Hypertension; 2010 Jun; 55(6):1418-24. PubMed ID: 20404218
[TBL] [Abstract][Full Text] [Related]
3. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
Krum H; Elsik M; Schneider HG; Ptaszynska A; Black M; Carson PE; Komajda M; Massie BM; McKelvie RS; McMurray JJ; Zile MR; Anand IS
Circ Heart Fail; 2011 Sep; 4(5):561-8. PubMed ID: 21750125
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
[TBL] [Abstract][Full Text] [Related]
5. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
[TBL] [Abstract][Full Text] [Related]
6. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
López B; González A; Lindner D; Westermann D; Ravassa S; Beaumont J; Gallego I; Zudaire A; Brugnolaro C; Querejeta R; Larman M; Tschöpe C; Díez J
Cardiovasc Res; 2013 Jul; 99(1):111-20. PubMed ID: 23619422
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
Bishu K; Deswal A; Chen HH; LeWinter MM; Lewis GD; Semigran MJ; Borlaug BA; McNulty S; Hernandez AF; Braunwald E; Redfield MM
Am Heart J; 2012 Nov; 164(5):763-770.e3. PubMed ID: 23137508
[TBL] [Abstract][Full Text] [Related]
10. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
Lindsay MM; Maxwell P; Dunn FG
Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
[TBL] [Abstract][Full Text] [Related]
12. Association between cystatin C and heart failure with preserved ejection fraction in elderly Chinese patients.
Xu CC; Fu GX; Liu QQ; Zhong Y
Z Gerontol Geriatr; 2018 Jan; 51(1):92-97. PubMed ID: 27206415
[TBL] [Abstract][Full Text] [Related]
13. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
[TBL] [Abstract][Full Text] [Related]
14. Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase.
López B; Querejeta R; González A; Larman M; Díez J
Hypertension; 2012 Sep; 60(3):677-83. PubMed ID: 22824984
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis).
Duprez DA; Gross MD; Kizer JR; Ix JH; Hundley WG; Jacobs DR
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475876
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
López B; González A; Querejeta R; Larman M; Díez J
J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
[TBL] [Abstract][Full Text] [Related]
17. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.
McNulty M; Mahmud A; Spiers P; Feely J
J Hum Hypertens; 2006 Nov; 20(11):867-73. PubMed ID: 16598292
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
López B; Ravassa S; González A; Zubillaga E; Bonavila C; Bergés M; Echegaray K; Beaumont J; Moreno MU; San José G; Larman M; Querejeta R; Díez J
J Am Coll Cardiol; 2016 Jan; 67(3):251-60. PubMed ID: 26796388
[TBL] [Abstract][Full Text] [Related]
19. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
van Empel VP; Mariani J; Borlaug BA; Kaye DM
J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
[TBL] [Abstract][Full Text] [Related]
20. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
